This report explores the key business strategies, resource capabilities, and environmental sustainability approaches of AstraZeneca, a pharmaceutical company. It discusses the use of Porter's generic strategies and Ansoff matrix to achieve competitive advantages, as well as the company's focus on cost leadership, differentiation, and market development. The report also evaluates AstraZeneca's resource capabilities using VRIO analysis and highlights its commitment to environmental sustainability through corporate social responsibility and transforming industrial sectors.